HIV Infection: Drugs
(asked on 11th February 2020) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care, of 28 January 2020, Official Report column 658, what steps he is taking to ensure that PReP is accessible to women; and how the roll-out of PReP to women is monitored by his Department.
A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations, including women. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:
https://www.prepimpacttrial.org.uk/faqs
A subgroup of the PrEP CAB aims to specifically address PrEP Impact Trial access for women. The subgroup has developed a questionnaire to use with women attending sexual health clinics in order to increase knowledge and awareness among women and to aid discussions about PrEP with health workers. More information can be found at the following link:
https://sophiaforum.net/index.php/women-and-prep/
In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women; information on the projects funded in 2018 can be found at the following link:
https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018
As at October 2019, places filled by women and other groups account for over 4% of total trial participants. As of 12 February 2020, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link: